Nasdaq:US$16.21 (-0.64) | HKEX:HK$26.45 (+1.00) | AIM:£2.72 (+0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice